Health & Wellness The Bone Health Debate: Investigating the Impact of GLP-1 Agonists on Skeletal Integrity October 24, 2026 Raul Delapena Setiawan For millions of Americans, the advent of glucagon-like peptide-1 (GLP-1) receptor agonists—marketed as Ozempic, Wegovy, and Zepbound—has heralded a new era in the treatment of obesity and type 2 diabetes.…
